Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.24 AUD | -4.00% | +41.18% | +37.14% |
May. 29 | Study Finds Cleo Diagnostics ' Blood Test Outperforms Clinical Benchmarks | MT |
Apr. 11 | Cleo Diagnostics Taps Lindus Health to Manage US Ovarian Cancer Clinical Trials | MT |
- Stock Market
- Equities
- COV Stock
- News Cleo Diagnostics Ltd
- Analyst Reco.